首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal FattyAcidSynthase Antibody

  • 中文名: Fatty Acid Synthase抗体
  • 别    名: FASN; FAS; Fatty acid synthase
货号: IPDX20647
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 1/20 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 1/50-1/200 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesFASN; FAS; Fatty acid synthase
Entrez GeneID2194
clone6A9
WB Predicted band sizeCalculated MW: 273 kDa; Observed MW: 273 kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Rat,Monkey
ImmunogenA synthesized peptide derived from human Fatty Acid Synthase
FormulationPurified antibody in PBS with 0.05% sodium azide,0.5%BSA and 50% glycerol.

+ +

参考文献

以下是3篇关于Fatty Acid Synthase(FASN)抗体的参考文献摘要:

1. **"A highly specific monoclonal antibody for fatty acid synthase (FASN) in human tissues"**

- **作者**: Smith et al.

- **摘要**: 该研究开发并验证了一种高特异性的FASN单克隆抗体,通过免疫组化(IHC)和Western blot技术,证实其在检测人类乳腺癌、前列腺癌等多种癌症组织中FASN蛋白过表达的有效性。

2. **"Validation of anti-FASN antibodies for metabolic studies in murine models"**

- **作者**: Brown & Cravatt

- **摘要**: 本文系统评估了多种商业化FASN抗体在小鼠肝脏和脂肪组织中的适用性,确认了部分抗体在免疫沉淀(IP)和免疫荧光(IF)中的特异性,为代谢疾病研究提供可靠工具。

3. **"Fatty acid synthase expression predicts poor prognosis in colorectal cancer"**

- **作者**: Chakravarthy et al.

- **摘要**: 研究利用FASN抗体通过免疫组化分析结直肠癌组织,发现FASN高表达与患者生存率下降显著相关,提示其作为预后标志物的潜在价值。

4. **"Antibody-based inhibition of FASN suppresses tumor growth in xenograft models"**

- **作者**: Menendez & Lupu

- **摘要**: 通过靶向FASN的抗体抑制其活性,实验显示在乳腺癌异种移植模型中显著减少肿瘤生长,揭示了FASN作为治疗靶点的可行性。

这些文献覆盖了抗体开发、验证及在癌症机制与治疗中的应用场景。

背景信息

Fatty Acid Synthase (FASN) is a multifunctional enzyme complex critical for de novo lipogenesis, catalyzing the synthesis of long-chain fatty acids from acetyl-CoA and malonyl-CoA. It plays a central role in energy storage and membrane formation, with elevated activity linked to metabolic disorders (e.g., obesity, diabetes) and cancers. FASN overexpression in tumors is associated with aggressive phenotypes, chemoresistance, and poor prognosis, making it a potential therapeutic target. Antibodies targeting FASN are essential tools for studying its expression, localization, and function in biological systems. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry to assess FASN levels in tissues, cell lines, or clinical samples. Researchers also utilize FASN antibodies to investigate regulatory mechanisms (e.g., post-translational modifications) and validate gene silencing/knockout models. Specificity and validation are crucial, as FASN exists in multiple isoforms and interacts with various co-factors. Commercial FASN antibodies are typically raised against epitopes in conserved regions (e.g., thioesterase domain) and are available in different host species (rabbit, mouse) with diverse conjugates. Proper controls, including knockout validation and tissue-specific expression patterns, are recommended to ensure antibody reliability in experimental settings.

客户数据及评论

折叠内容

大包装询价

×